Search Results

started with a thesis project, a new chemical strategy, and a vision to make fluorescence available for drug discovery. GPCR to connect with the researchers who need them most. ✳️ Learn more about the partnership: https:/ to with a thesis project, a new chemical strategy, and a vision to make fluorescence available for drug discovery.

with numerous pharma and biotechs in understanding and applying in vitro pharmacology data to advance drug discovery. He specializes in kinetic analysis of drug action and is known for applying binding kinetics to the development He guided the in vitro biology efforts of the company for numerous drug discovery campaigns. GPCR Member ResearchGate Dr. GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.

target discovery. GPCR Targeted Drugs and Gene Regulation in Cancer Cells Mike presented research on the effect of GPCR-targeted lab, which led to the discovery of potential tumor suppressors and oncogenes in melanoma. Scientific Journey and Drug Discovery Challenges Mike shared significant moments in his scientific journey , including the discovery of RGS proteins and its impact on his research approach.

Explore the kinetic principles behind persistent binding and smarter drug design. Home → Flash News → irreversible drugs post 2 Persistent binding ≠ just covalent. Published on October 24, 2025 Category Terry's Corner Why do some inhibitors act long after the drug If your discovery strategy still treats kinetics as an afterthought, you’re already behind. ✳️ Read More #GPCR #DrGPCR #Pharmacology #DrugDiscovery #BindingKinetics #ReceptorPharmacology #MedicinalChemistry

Can models predict drug outcomes? Jens Carlsson shares how GPCR modeling is moving from explanation to real prediction in drug discovery Bridging computation, chemistry, and pharmacology is key to speeding up drug discovery. discovery. science, and what that means for the future of drug discovery.

Juan José Fung is a Principal Scientist at GPCR Therapeutics, Inc , a drug discovery company focused spent significant time in the industry studying membrane proteins, antibodies, and HTS methods for drug discovery. Juan José Fung on the web LinkedIn GPCR Therapeutics Dr. GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.

Home → Flash News → Generic tools won’t solve tomorrow’s drug discovery challenges. GPCR and Celtarys joining forces, expect more visibility, more precision, and more scientific impact. 🚀 Get to know our media partner: https://www.ecosystem.drgpcr.com/celtarys-research-dr-gpcr-ecosystem CustomLigands Published on June 27, 2025 Category Celtarys - Media Partner Generic tools won’t solve tomorrow’s drug discovery challenges.

Home → Flash News → How sensitive can a GPCR really be How sensitive can a GPCR really be? GPCR Podcast Think femtomolar. That’s the scale we’re talking about. This week on the Dr. How disease can hijack signaling organization — and what that means for drug discovery. . 🔗 Listen here → https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/leadership-luck-and-gpcr-signaling GPCR Premium → https://www.ecosystem.drgpcr.com/gpcr-university #GPCR #DrGPCR #pharmacology #drugdiscovery

Terry Kenakin is hosting a 4-week course on GPCR drug development—and registration closes in 3 days! 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr. Terry Kenakin is hosting a 4-week course on GPCR drug development —and registration closes in 3 days! 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr. GPCR Ecosystem #GPCR #DrGPCR #Pharma #Biotech #Research Previous Next Recent Articles

GPCR Happy Hour – Connect, Collaborate, Discover A global networking event where GPCR scientists break Scientist-led : Built by GPCR researchers, for GPCR researchers. GPCR & Partners) Upcoming and Past Happy Hours GPCR Happy Hour – Boston, Sept 2025 Every September, Boston welcomes the global biotech and drug discovery community. GPCR Happy Hour Dr. GPCR News Aug 20 3 min read

GPCR collaboration at Monash shows how shared lab ecosystems can reshape innovation and accelerate drug discovery. Home → Flash News → How GPCR Collaboration Built an Innovation Engine How GPCR Collaboration Built an GPCR Podcast Collaboration isn’t a soft skill — it’s an innovation strategy. GPCR Premium #GPCR #DrGPCR #DrugDiscovery #Innovation #ScienceLeadership #Collaboration Previous Next

GPCR Podcast Strategic Partners Dr. Daniel Wacker About Dr. and in vitro drug discovery. Icahn School of Medicine at Mount Sinai in NYC, where I have been working on structure-function and drug discovery of GPCRs and transporters. GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.

signaling opens new doors in drug discovery. From early discoveries in cyclic AMP signaling to uncovering ultrasensitive receptor responses at femtomolar the Guest Michelle Halls is an Associate Professor at Monash University and Deputy Theme Leader of Drug Discovery Biology at Monash Institute of Pharmaceutical Sciences. GPCR Premium .

Home → Flash News → 🚀 Ready to dive into the world of GPCR drug development? Join Dr. Terry Kenakin for the 4-week course “Development of GPCR Ligands as Therapeutic Drugs”! 👉 https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs GPCR Courses 🚀 Ready to dive into the world of GPCR drug development? Join Dr. Terry Kenakin for the 4-week course “Development of GPCR Ligands as Therapeutic Drugs”!

Medicines Theme Leader of the Neuromedicines Discovery Centre at the Monash Institute of Pharmaceutical ) and is the co-founder and CEO of Phrenix Therapeutics, a biotech spin-out from the Neuromedicines Discovery He is an acknowledged expert in drug discovery, particularly in the field of psychiatry, where he has He has published over 70 research articles, reviews and book chapters on drug discovery, which have been GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.

engaged in researching molecular mechanisms that govern human (patho-)physiology and their interplay with drugs I aim to discover new therapeutic approaches, and druggable molecules or refine canonical drug targets to create drugs with fewer adverse effects. I want to combine experimental approaches with data-driven discovery and adopt data science methodology GPCR Enjoying the Dr. GPCR Podcast? Leave a Review.

level of organization defines specificity in signaling, and understanding it changes how we think about drug signaling: 👉 https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/leadership-luck-and-gpcr-signaling #GPCR Next Recent Articles Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism Drug discovery often assumes receptor inhibition follows simple rules—agonist binds, antagonist blocks, and GPCR Podcast 4 days ago Molecular creativity in drug discovery Most pharmacologists are trained to chase

Dr GPCR is a 501(c)(3) non-profit. Support the GPCR Community — Empower the Next Generation of Discovery Your donation helps us serve the global GPCR community better — by upgrading the Dr GPCR University, creating more learning opportunities research, collaboration, and discovery. Together, we can accelerate GPCR discoveries and develop more effective drugs for everyone. 👉 Donate

receptors involved in many, if not all, physiological responses, with the ultimate goal of improving drug in-cellulo measurement of protein-protein interactions, receptor trafficking and signalling, useful for drug discovery programs. GPCR Previous Event Next Event Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires 22nd GPCR Retreat Sponsored by

GPCR University: "Development of GPCR Ligands as Therapeutic Drugs." 🗓 Dates: March 20 - April 10, 2025 Gain deep insights into GPCR drug candidates and learn the critical assays and techniques required to GPCR Courses 🚨 Exciting Opportunity for Professionals in Drug Development! GPCR University: "Development of GPCR Ligands as Therapeutic Drugs." 🗓 Dates: March 20 - April 10, 2025 Gain deep insights into GPCR drug candidates and learn the critical assays and techniques required to

GPCR Podcast Strategic Partners Eleonora Comeo About this episode Eleonora Comeo is a doctoral candidate in Medicinal Chemistry and Drug Discovery in the joint program of the University of Nottingham in the We sat down to chat about GPCRs, synthesizing labeled ligands, and her unique position that allows her to work with GPCR scientists on 2 continents. GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.

Ligands as Therapeutic Drugs,” with Dr. Premium Membership 🚀 ✳️Go to https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs of GPCR Ligands as Therapeutic Drugs,” with Dr. Premium Membership 🚀 ✳️Go to https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs #gpcr #drgpcr Previous Next Recent Articles

Home → Flash News → terrys corner predict drug behavior Published on July 12, 2025 Category Terry's Corner Dive into the logic of drug modeling with Terry Kenakin. Learn to “extend your eyes” and predict complex drug behaviors. 🟢 Browse the full catalog (and expect ✳️ https://www.terrykenakin.com #pharmacology #drugmechanism #kenakin #GPCR #DrGPCR Previous Next Recent

GPCR Podcast Strategic Partners Dr. Oliver Hartley About Dr. Oliver Hartley Oliver Hartley is VP for Drug Discovery at Orion Biotechnology . He is the inventor of OB-002 as well as the key technology underlying Orion’s discovery platform. GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review. Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

GPCR Podcast Strategic Partners Dr. Josephine (Pina) Cardarelli About Dr. Cardarelli is a drug development leader with extensive experience driving drug discovery teams in bringing She oversaw early discovery programs IL-23 p19 and IL23 p19/IL-17 bispecifics. She has extensive experience working with Biologics, and Antibody Drug Conjugates as well as experience GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.

GPCR Podcast Strategic Partners Murat Tunaboylu & Ben Holland About Murat Tunaboylu "Murat Tunaboylu, His current focus is to realise Antiverse’s mission: engineering the future of drug discovery." Murat Tunaboylu on the web Antiverse DSV Future of Drug Discovery Podcast Twist Bioscience LinkedIn Twitter GPCR Enjoying the Dr. GPCR Podcast? Leave a Review. Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Home → Flash News → terrys corner model drug response Published on July 10, 2025 Category Terry's Corner What if a single experimental snapshot could predict an entire in vivo drug profile in a range of organs discussed. 🟢 Read the full breakdown: ✳️ https://www.ecosystem.drgpcr.com/post/what-if-you-could-predict-drug-behavior-with-just-a-snapshot #GPCR #DrGPCR #pharmacology #DrugDiscovery #TerryKenakin #FoundationalScience Previous Next Recent Articles

GPCR location within the cell can change everything: function, pharmacology, and even drug response. from the lab to the broader biotech world This episode is packed with knowledge for scientists, drug GPCR Podcast 🎧 Why Does GPCR Location Make All the Difference? GPCR location within the cell can change everything: function, pharmacology, and even drug response. from the lab to the broader biotech world This episode is packed with knowledge for scientists, drug

Terry Kenakin, “Development of GPCR Ligands as Therapeutic Drugs” is coming up 🧐 Be the first to register ✳️Go to https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs Terry Kenakin, “Development of GPCR Ligands as Therapeutic Drugs” is coming up 🧐 Be the first to register ✳️Go to https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs #gpcr #drgpcr Previous Next Recent Articles

GPCR Podcast Strategic Partners Dr. JoAnn Trejo About Dr. JoAnn Trejo Dr. biology and for the identification of drug targets and future drug development. which has important functions in hemostasis, thrombosis, inflammation, and cancer and is an important drug She has made numerous important discoveries related to the mechanisms that control PAR1 signaling and GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.